Maternal exposure to low doses of Δ9-tetrahydrocannabinol facilitates morphine-induced place conditioning in adult male offspring

Pharmacology Biochemistry and Behavior

Volumn 61, Issue 3, 1998, Pages 229-238

  Rubio, Pilar ^a   De Fonseca, Fernando Rodríguez ^a   Martín Calderón, José Luis ^a   Del Arco, Ignacio ^a   Bartolomé, Sandra ^a   Villanúa, María Angeles ^a   Navarro, Miguel ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

ACTH; Cannabinoids; Conditioning; Corticosterone; Morphine; Perinatal exposure; Rat; Reinforcement

Indexed keywords

DRONABINOL; MORPHINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; EXPLORATORY BEHAVIOR; FEMALE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REINFORCEMENT;

ADRENOCORTICOTROPIC HORMONE; ANALYSIS OF VARIANCE; ANIMALS; CONDITIONING (PSYCHOLOGY); CORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HALLUCINOGENS; LACTATION; MALE; MATERNAL EXPOSURE; MORPHINE; NARCOTICS; RATS; RATS, WISTAR; REINFORCEMENT (PSYCHOLOGY); TETRAHYDROCANNABINOL;

EID: 0031792703     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00099-9     Document Type: Article

References (50)

1. Bonnin, A.; de Miguel, R.; Rodríguez-Manzaneque, J. C.; Fernández-Ruiz, J. J.; Santos, A.; Ramos, J. A.: Changes in tyrosine hydroxylase gene expression in mesencephalic catecholaminergic neurons of immature and adult male rats perinatally exposed to cannabinoids. Dev. Brain Res. 81:147-153; 1994.
2. Brake, S. C.; Hutchings, D. E.; Morgan, B.; Lasalle, E.; Shi, T.: Delta-9-tetrahydrocannabinol during pregnancy in the rat: II Effects on ontogeny of locomotor activity and nipple attachment in the offspring. Neurotoxicol. Teratol. 9:45-49; 1987.
3. Callaghan, P. M.; Delagarza, R.; Cunnighan, K. A.; Henry, C.; Kabbaj, M.; Simon, H.; Le Moal, M.; Maccari, S.: Prenatal stress increases the hypothalamo-pituitary-adrenal axis response in young and adult rats. J. Neuroendocrinol. 6:341-345; 1994.
4. Comings, D. E.; Muhleman, D.; Gade, R.; Johnson, P.; Verde, R.; Sancier, G.; MacMurray, J.: Cannabinoid receptor gene association with i.v. drug use. Mol. Psychiatry 2:161-168; 1997.
5. Dalterio, S.; Bartke, A.: Perinatal exposure to cannabinoids alters male reproductive function in mice. Science 205:1420-1422; 1979.
6. Day, N. L.; Richardson, G. A.; Goldschmidt, L.; Robles, N.; Taylor, P. M.; Stoffer, D. S.; Cornelius, M. D.: Effect of prenatal marijuana exposure on the cognitive development of offspring at age three. Neurotoxicol. Teratol. 16:169-175; 1994.
7. Deminiere, J. M.; Piazza, P. V.; Guegan, G.; Abrous, N.; Maccari, S.; Le Moal, M.; Simon, H.: Increased locomotor response to novelty and propensity to intravenous amphetamine self-administration in adult offspring of stressed mothers. Brain Res. 586:135-139; 1992.
8. Dewey, W. L.: Cannabinoid pharmacology. Pharmacol. Rev. 38:151-178; 1986.
9. Fernández-Ruiz, J. J.; Rodríguez de Fonseca, F.; Navarro, M.; Ramos, J. A. Maternal cannabinoid exposure and brain development: Changes in the ontogeny of dopaminergic neurons. In: Bartke, A.; Murphy, L. L., eds. Neurobiology and neurophysiology of cannabinoids (Biochemistry and physiology of substance abuse, vol. IV). Boca Raton, FL: CRC Press; 1992:119-164.
10. 9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther. 272:699-707; 1995.
11. Fried, P. A.: The Ottawa prenatal prospective study (OPPS): Methodological issues and findings. It is easy to throw the baby out with the bath water. Life Sci 56:2159-2168; 1995.
12. Gagin, R.; Kook, N.; Cohen, E.; Shavit, Y.: Prenatal morphine enhances morphine-conditioned place preference in adult rats. Pharmacol. Biochem. Behav. 58:525-528; 1997.
13. Hammer, R. P., Jr.: The sex-hormone-dependent development of opiate receptors in the rat medial preoptic area. Brain Res. 360:65-72; 1985.
14. Hand, T. H.; Stinus, L.; Le Moal, M.: Differential mechanisms in the acquisition and expression of heroin-induced place preference. Psychopharmacology (Berlin) 98:61-67; 1989.
15. Holson, R. R.; Pearce, B.: Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species. Neurotoxicol. Teratol. 14:221-228; 1992.
16. Hutchings, D. E.; Martin, B. R.; Gamagaris, Z.; Miller, N.; Fico, T.: Plasma concentrations of delta-9-tetrahydrocannabinol in dams and fetuses following acute or multiple prenatal dosing in rats. Life Sci. 44:697-701; 1989.
17. Hutchings, D. E.; Morgan, B.; Brake, S. C.; Shi, T.; Lasalle, E.: Delta-9-tetrahydrocannabinol during pregnancy in the rat: I. Differential effects on maternal nutrition, embryotoxicity, and growth in the offspring. Neurotoxicol. Teratol. 9:39-43; 1987.
18. Insel, T. R.; Kinsley, C. H.; Mann, P. E.; Bridges, R. S.: Prenatal stress has long-term effects on brain opiate receptors. Brain Res. 511:93-97; 1990.
19. 14-C-tetrahydrocannabinol to the mother. Eur. J. Pharmacol. 22:221-223; 1977.
20. Keller, R. W., Jr.; Lefevre, R.; Raucci, J.; Carlson, J. N.; Glick, S. D.: Enhanced cocaine self-administration in adult rats prenatally exposed to cocaine. Neurosci. Lett. 205:153-156; 1996.
21. Keshet, G. I.; Weinstock, M.: Maternal naltrexone prevents morphological and behavioral alterations induced in rats by prenatal stress. Pharmacol. Biochem. Behav. 50:413-419; 1995.
22. Kumar, A. M.; Haney, M.; Becker, T.; Thompson, M. L.; Kream, R. M.; Miczek, K.: Effect of early exposure to delta-9-tetrahydrocannabinol on the levels of opioid peptides, gonadotrophin-releasing hormone and substance P in the adult male rat brain. Brain Res. 525:78-83; 1990.
23. Maccari, S.; Piazza, P. V.; Deminiere, J. M.; Lemaire, V.; Mormede, P.; Simon, H.; Angelucci, L.; Le Moal, M.: Life events-induced decrease of corticosteroid type-I receptors is associated with reduced corticosterone feedback and enhanced vulnerability to amphetamine self-administration. Brain Res. 547:7-12; 1991.
24. Martín, S.; Crespo, J. A.; Ferrado, R.; García-Lecumberri, C.; Gil, L.; Ramos, J. A.; Fernández-Ruiz, J. J.; Diez, N.; Manzanares, J.; Ambrosio, E.: Effects of Delta-9-THC perinatal treatment of mothers on morphine and food operant reinforced behaviors in the adult offspring. Soc. Neurosci. Abstr. 22:167; 1996.
25. McCormick, C. M.; Smythe, J. W.; Sharma, S.; Meaney, M.: Sex-specific effects of prenatal stress on hypothalamic-pituitary-adrenal responses to stress and brain glucocorticoid receptor density in adult rats. Brain Res. 84:55-61; 1995.
26. McEwen, B. S.: Steroid hormones and brain development: Some guidelines for understanding actions of pseudohormones and other toxic agents. Environ. Health Perspect. 74:177-192; 1987.
27. Mirmiran, M.; Swaab, D. F.: Influence of drugs on brain neurotransmission and behavioral stages during development. Dev. Pharmacol. Ther. 10:377-384; 1987.
28. Molina, V. A.; Wagner, J. M.; Spear, L. P.: The behavioral response to stress is altered in adult rats exposed perinatally to cocaine. Physiol Behav 55:941-945; 1994.
29. 9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity. Behav. Brain Res. 5:37-46; 1993.
30. Navarro, M.; Rodríguez de Fonseca, F.; Hernández, M. L.; Ramos, J. A.; Fernández-Ruiz, J. J.: Changes in the adult motor behavior following perinatal cannabinoid exposure in rats: Involvement of nigrostriatal dopaminergic activity. Pharmacol. Biochem. Behav. 47:47-58; 1994.
31. 9-tetrahydrocannabinol. An ontogenic study in wistar rats. Psychopharmacology (Berlin) 116:414-422; 1994.
32. Navarro, M.; de Miguel, R.; Rodríguez de Fonseca, F.; Ramos, J. A.; Fernández-Ruiz, J. J.: Perinatal cannabinoid exposure modifies the sociosexual approach behavior and the mesolimbic dopaminergic activity of adult male rats. Behav. Brain Res. 75:91-98; 1996.
33. Piazza, P. V.; Deminiere, J. M.; Le Moal, M.; Simon, H.: Factors that predict individual vulnerability to amphetamine self-administration. Science 245:1511-1513; 1989.
34. Robins, L. N.; Mills, J. L.: Effects of in utero exposure to street drugs. Am. J. Public Health Suppl. 83:8-32; 1993.
35. Rodríguez de Fonseca, F.; Carrea, M. R. A.; Navarro, M.; Koob, G. F.; Weiss, F.: Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 276: 2050-2054; 1997.
36. Rodríguez de Fonseca, F.; Cebeira, M.; Fernández-Ruiz, J. J.; Navarro, M.; Ramos, J. A.: Effects of pre- and perinatal exposure to hashish extracts on the ontogeny of brain dopaminergic neurons. Neuroscience 43:713-723; 1991.
37. Rodríguez de Fonseca, F. A.; Fernández-Ruiz, J. J.; Eldridge, J. C.; Steger, R. W.; Bartke, A.; Murphy, L. L.: Effects of the exposure to delta-9-tetrahydrocannabinol on the adrenal medullary function: Evidence of an acute effect and development of tolerance in chronic treatments. Pharmacol. Biochem. Behav. 40:593-598; 1991.
38. Rodríguez de Fonseca, F.; Ramos, J. A.; Bonnin, A; Fernández-Ruiz, J. J.: Presence of cannabinoid binding sites in the brain from early postnatal ages. Neuroreport 4:135-138; 1993.
39. Rodríguez de Fonseca, F.; Rubio, P.; Martín-Calderón, J. L.; Caine, S. B.; Koob, G. F.; Navarro, M.: The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference. Eur. J. Pharmacol. 274:47-55; 1995.
40. 2 receptor agonists on the acute neuroendocrine actions of the highly potent synthetic cannabinoid HU-210 in male rats. Neuroendocrinology 61:714-721; 1995.
41. 37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats. J. Pharmacol. Exp. Ther. 276:56-64; 1996.
42. 9-tetrahydrocannabinol toxicity in rats treated for periods up to six months. Toxicol. Appl. Pharmacol. 32:399-417; 1975.
43. 9-tetrahydrocannabinol in rats: possible role of pituitary-adrenal axis. Life Sci. 56:2169-2176; 1995.
44. Shaham, Y.; Stewart, J.: Stress reinstates heroin-seeking in drug-free animals: An effect mimicking heroin, not withdrawal. Psychopharmacology (Berlin) 119:334-341; 1995.
45. 1 opioid receptor mechanism. Science 276:2048-2050; 1997.
46. Taylor, A. N.; Branch, B. J.; Nelson, L. R.; Fane, L. A.; Poland, R. E.: Prenatal ethanol and ontogeny of pituitary-adrenal responses to ethanol and morphine. Alcohol 3:255-259; 1986.
47. 9-tetrahydrocannabinol leads to changes in opioid-related behavioral patterns in rats. Brain Res. 680:142-147; 1995.
48. Walters, D. E.; Carr, L. A.: Changes in brain catecholamine mechanisms following perinatal exposure to marihuana. Pharmacol. Biochem. Behav. 25:763-778; 1986.
49. Ward, I. L.; Weisz, J.: Differential effects of maternal stress on circulating levels of corticosterone, progesterone and testosterone in male and female rat fetuses and their mothers. Endocrinology 114:1635-1644; 1984.
50. Zuckerman, B.: Drug effects - A search for mechanisms. In: Kilbey, M. N.; Asghar, K., eds. Methodological issues in controlled studies on effects of prenatal exposure to drug abuse. NIDA Res. Mongr., vol. 114. Rockville, Maryland 1991:352-362.